Insider · CIK 0001854977
Kennedy Lewis Investment Holdings II LLC
Files at KODK (EASTMAN KODAK CO), DOUG (Douglas Elliman Inc.). First filing -, latest -.
Kennedy Lewis Investment Holdings II LLC files SEC Form 4 as director at KODK (EASTMAN KODAK CO), and also at DOUG (Douglas Elliman Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kennedy Lewis Investment Holdings II LLC has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | KODK EASTMAN KODAK CO | DDisposition to issuer 4.0% Series B Convertible Preferred Stockderivativeindirect: See Footnotes | -746,620 | - | - | 0 | Mar 12, 2026 |
| Mar 11, 2026 | KODK EASTMAN KODAK CO | DDisposition to issuer 4.0% Series B Convertible Preferred Stockderivativeindirect: See Footnotes | -69,171 | - | - | 0 | Mar 12, 2026 |
| Mar 11, 2026 | KODK EASTMAN KODAK CO | DDisposition to issuer 4.0% Series B Convertible Preferred Stockderivativeindirect: See Footnotes | -5,730 | - | - | 0 | Mar 12, 2026 |
| Mar 11, 2026 | KODK EASTMAN KODAK CO | DDisposition to issuer 4.0% Series B Convertible Preferred Stockderivativeindirect: See Footnotes | -178,479 | - | - | 0 | Mar 12, 2026 |
| Mar 11, 2026 | KODK EASTMAN KODAK CO | AGrant or award 6.0% Series B Convertible Preferred Stockderivativeindirect: See Footnotes | +746,620 | - | - | 746,620 | Mar 12, 2026 |
| Mar 11, 2026 | KODK EASTMAN KODAK CO | AGrant or award 6.0% Series B Convertible Preferred Stockderivativeindirect: See Footnotes | +69,171 | - | - | 69,171 | Mar 12, 2026 |
| Mar 11, 2026 | KODK EASTMAN KODAK CO | AGrant or award 6.0% Series B Convertible Preferred Stockderivativeindirect: See Footnotes | +5,730 | - | - | 5,730 | Mar 12, 2026 |
| Mar 11, 2026 | KODK EASTMAN KODAK CO | AGrant or award 6.0% Series B Convertible Preferred Stockderivativeindirect: See Footnotes | +178,479 | - | - | 178,479 | Mar 12, 2026 |
| Dec 5, 2025 | KODK EASTMAN KODAK CO | POpen-market purchase 4.0% Series B Convertible Preferred Stockderivativeindirect: See Footnotes | +746,620 | $101.50 | $76M | 746,620 | Dec 5, 2025 |
| Dec 5, 2025 | KODK EASTMAN KODAK CO | POpen-market purchase 4.0% Series B Convertible Preferred Stockderivativeindirect: See Footnotes | +69,171 | $101.50 | $7.0M | 69,171 | Dec 5, 2025 |
| Dec 5, 2025 | KODK EASTMAN KODAK CO | POpen-market purchase 4.0% Series B Convertible Preferred Stockderivativeindirect: See Footnotes | +5,730 | $101.50 | $582k | 5,730 | Dec 5, 2025 |
| Dec 5, 2025 | KODK EASTMAN KODAK CO | POpen-market purchase 4.0% Series B Convertible Preferred Stockderivativeindirect: See Footnotes | +178,479 | $101.50 | $18M | 178,479 | Dec 5, 2025 |
Questions about Kennedy Lewis Investment Holdings II LLC
Answered from the filings on this page, as of the latest one.
Is Kennedy Lewis Investment Holdings II LLC buying or selling?
Kennedy Lewis Investment Holdings II LLC has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kennedy Lewis Investment Holdings II LLC's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kennedy Lewis Investment Holdings II LLC has 0.
Where does Kennedy Lewis Investment Holdings II LLC file Form 4?
Kennedy Lewis Investment Holdings II LLC has filed Form 4 at KODK (EASTMAN KODAK CO); DOUG (Douglas Elliman Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.